To promote informed decision making in selecting appropriate interventions to address complex issues faced by health and pharmaceutical systems, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program has prepared this guidance document for technical assistance providers, policymakers, and key stakeholders in pharmaceutical systems to use as they consider system improvements and … Read more
The efficient use of existing resources is an essential component of a sustainable and resilient pharmaceutical system. SIAPS-South Africa has used various capacity-building strategies to improve the decision-making process in the selection of cost-effective and affordable medicines for the public sector, and to promote the monitoring and analysis of pharmaceutical expenditure. To that effect, SIAPS-South … Read more
In 2012, the National Medicines Management Team (Unidad Nacional de Gestión de Medicamentos; UNGM), in coordination with the General Directorate for Control of Sexually Transmitted Infections and AIDS (Dirección General de Control de las Infecciones de Transmisión Sexual y SIDA) and the National Council on HIV and AIDS (Consejo Nacional de VIH y el SIDA; … Read more
The state of tuberculosis (TB) is in a tug-of-war as current challenges threaten to undo past successes. One of the primary hurdles currently facing TB prevention and cure is the emergence of strains that are resistant to at least two of the most effective medicines (rifampicin and isoniazid). So-called drug-resistant (DR)-TB arises when patients are … Read more
Although tuberculosis (TB) has existed for thousands of years, new tools for diagnosing and treating it are quickly changing the way in which countries plan TB care and treatment programs. The National Tuberculosis Programs (NTPs) in most low-income countries depend heavily on international donor funding. With recent declines in foreign assistance, however, increased awareness about … Read more
